These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 410992

  • 1. [Comparison of the therapeutic effects of secondary antituberculous drugs and evaluation of back-ground factors of the patients to the negative conversion of bacilli among the previously treated severe tuberculosis patients (author's transl)].
    Yamamoto M, Sassa H, Suzuki T, Morishita M, Nagata A.
    Kekkaku; 1977 Aug; 52(8):399-404. PubMed ID: 410992
    [No Abstract] [Full Text] [Related]

  • 2. [The relation between bacilli negative conversion rate and the number of combined sensitive antituberculous drugs in intermittent administration of rifampicin for severe pulmonary tuberculosis].
    Tamura M, Yamazaki A, Tamura T, Takano S, Yamazaki M.
    Kekkaku; 1973 Jul; 48(7):297-302. PubMed ID: 4200058
    [No Abstract] [Full Text] [Related]

  • 3. [A study on prevalence of resistance to primary and secondary drugs among newly admitted pulmonary tuberculosis patients in 1977. Part 1. Comparison of results in 1977 with those in 1957, '59, '61, '63, '66, '69 and '72 (author's transl)].
    Kekkaku; 1979 Nov; 54(11):515-22. PubMed ID: 118298
    [No Abstract] [Full Text] [Related]

  • 4. [A study of prevalence of resistance to major drugs among newly admitted pulmonary tuberculosis patients in 1972. Part 2. Studies on the factors related to the prevalence of drug resistance (author's transl)].
    Gomi J, Chiba Y, Yanagisawa K.
    Kekkaku; 1975 Feb 15; 50(2):55-62. PubMed ID: 815707
    [No Abstract] [Full Text] [Related]

  • 5. [Direct and late results of the treatment of severe cases of primary tuberculosis by Pronisone and antituberculous drugs (author's transl)].
    Djurić-Milosavljević O, Moskovljević D.
    Plucne Bolesti Tuberk; 1979 Feb 15; 31(3-4):125-9. PubMed ID: 538114
    [No Abstract] [Full Text] [Related]

  • 6. [2 cases of drug-resistant pulmonary tuberculosis treated with ofloxacin].
    Krasucka-Kluźniak A, Krakówka P.
    Pneumonol Pol; 1989 Apr 15; 57(4):249-52. PubMed ID: 2516906
    [Abstract] [Full Text] [Related]

  • 7. [Treatment and outcomes of disseminated pulmonary tuberculosis].
    Rzhavskov IV, Lishchinskii AB, Znosenko VA.
    Probl Tuberk; 1997 Apr 15; (1):40-1. PubMed ID: 9162924
    [Abstract] [Full Text] [Related]

  • 8. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV, Pashkov IuN, Pospelov VV.
    Probl Tuberk; 1981 Dec 15; (12):30-4. PubMed ID: 6801646
    [No Abstract] [Full Text] [Related]

  • 9. [Side effects of antituberculous drugs observed within six months after admission. Tuberculosis Research Committee, Ryoken (author's transl)].
    Kekkaku; 1975 Jun 15; 50(6):161-7. PubMed ID: 1185917
    [No Abstract] [Full Text] [Related]

  • 10. [Bacteriological relapse among the previously treated advanced pulmonary tuberculosis patients whose sputum converted to negative by the rifampicin treatment, with special reference to the duration of rifampicin administration (author's transl)].
    Yamamoto M, Morishita M, Hirano Y, Nagata A, Yazaki M.
    Kekkaku; 1974 Jul 15; 49(7):195-9. PubMed ID: 4214961
    [No Abstract] [Full Text] [Related]

  • 11. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T, Hasegawa N, Satou R, Komatsu H, Kawada K.
    Kekkaku; 1998 Jul 15; 73(7):471-6. PubMed ID: 9739579
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of tuberculosis patients with massive bacterial excretion].
    Gavril'ev SS, Vinokurova MK.
    Probl Tuberk; 1997 Jul 15; (2):17-8. PubMed ID: 9235572
    [Abstract] [Full Text] [Related]

  • 13. [Studies of the effect of antituberculosis agents against tubercle bacilli of the chronic tuberculosis in mice].
    Mabuchi H.
    Bull Chest Dis Res Inst Kyoto Univ; 1980 Mar 15; 13(1-2):25-31. PubMed ID: 6821504
    [No Abstract] [Full Text] [Related]

  • 14. [Dynamics of the excretion of the bacilli in patients with destructive pulmonary tuberculosis under the effect of long-term tuberculostatic therapy].
    Fisher EF, Velichko SA, Sharaburova OE, Strelis AK.
    Lab Delo; 1973 Mar 15; 6():340-2. PubMed ID: 4129386
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN, Hong SB, Oh YM, Kim MN, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS.
    J Antimicrob Chemother; 2006 Sep 15; 58(3):701-4. PubMed ID: 16857689
    [Abstract] [Full Text] [Related]

  • 16. [Effect of the inhalation of tuberculostatic aerosols on the dynamics of bacterial excretion in pulmonary tuberculosis patients].
    Protsiuk RG.
    Probl Tuberk; 1983 May 15; (5):38-42. PubMed ID: 6408637
    [No Abstract] [Full Text] [Related]

  • 17. [Rifampicin treatment for pulmonary tuberculosis--effectiveness of rifampicin on tubercle bacilli in pulmonary lesions (author's transl)].
    Kameda K, Okamura S, Yamamoto S, Iwai K.
    Kekkaku; 1975 Jul 15; 50(7):185-9. PubMed ID: 810614
    [No Abstract] [Full Text] [Related]

  • 18. [Evaluation of care for elderly pulmonary tuberculosis patients].
    Sasaki Y, Yamagishi F, Yagi T, Hashimoto T, Bekku R, Kawasaki T, Shinozaki A.
    Kekkaku; 2007 Oct 15; 82(10):733-9. PubMed ID: 18018597
    [Abstract] [Full Text] [Related]

  • 19. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
    Su WJ, Perng RP.
    Int J Tuberc Lung Dis; 2002 Nov 15; 6(11):1029-32. PubMed ID: 12475151
    [Abstract] [Full Text] [Related]

  • 20. [Logistic analysis on risk factors related to smear positive pulmonary tuberculosis].
    Li XT, Ye LX, Shi LY, Xiao AQ, Hou SY, Wang W, Ye JJ, Tang SW, Zhao HH, Xu HT.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug 15; 25(8):658-60. PubMed ID: 15555385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.